Spoiler Alert! The Greenfund tells you it is good.
I do not agree with some of this article - especially suggestions of BOT management shortcomings as for example the very notion of double-blind is IMO suggestive of a certain lack of control of events - but please read in its entirety and absorb the last two paragraphs:
"Our view and investing thesis has not changed. The drug is efficacious and safe and is targeting a significant addressable market. We are still firmly behind the management team and company and believe the current share price offers an unbelievably attractive opportunity for investors looking to initiate a position, or to dollar average down their existing position.
And this is exactly what we did yesterday."
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-509
-
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $624.4M |
Open | High | Low | Value | Volume |
34.0¢ | 35.0¢ | 34.0¢ | $436.1K | 1.258M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 358410 | 34.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.5¢ | 166658 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 356910 | 0.340 |
8 | 440293 | 0.335 |
9 | 262854 | 0.330 |
11 | 404976 | 0.325 |
16 | 637243 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 208524 | 3 |
0.350 | 210973 | 6 |
0.355 | 132212 | 7 |
0.360 | 359205 | 11 |
0.365 | 132250 | 6 |
Last trade - 11.00am 13/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online